Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/31/2003 | WO2002043578A3 Determination of risk and treatment of complications of prematurity |
12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
12/31/2003 | WO2002040650A3 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
12/31/2003 | WO2001006984A3 Small molecules useful in the treatment of inflammatory disease |
12/31/2003 | CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
12/31/2003 | CN1464791A Compositions for protein delivery via the pulmonary route |
12/31/2003 | CN1464046A Bacillus adhaerens and its use in preparing health food having thrombolysis property |
12/31/2003 | CN1463972A Novel N-substituted pyridine Benzisoxazolone compound, method for making same and its pharmaceutical composition and use thereof |
12/31/2003 | CN1463736A A pharmaceutical compound for treating coronary disease and stenocardia |
12/31/2003 | CN1463733A Plaster for treating hypertension |
12/31/2003 | CN1463729A Health care pillow containing traditional Chinese medicine |
12/31/2003 | CN1463727A A TCM compound recipe notoginseng capsule and method for preparing the same |
12/31/2003 | CN1463720A Ginseng-leech capsule for treating coronary disease and stenocardia and process for preparing same |
12/31/2003 | CN1463718A A process of preparing medicine for treating cardiac cerebral arteriosclerosis |
12/31/2003 | CN1463717A A process of preparing medicinal liquor for treating rheumatism and rheumatoid disease |
12/31/2003 | CN1463716A Medicament compound for preventing and treating stroke sequelae |
12/31/2003 | CN1463711A Radix salvia miltiorrhiza capsule compound and method for preparing same |
12/31/2003 | CN1463706A Bingliushui traditional Chinese medicament |
12/31/2003 | CN1463704A Novel usage of Aspirin-DL-Lysine |
12/31/2003 | CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
12/31/2003 | CN1132621C Tibetans medicine for treating cardiac and cerebral vascular disease and white pulse disease |
12/31/2003 | CN1132620C Aseptic 'Shenmai' powder for injection and its preparing process |
12/31/2003 | CN1132608C Chinese medicine for treating thromboangitis obliterans |
12/31/2003 | CN1132607C Yunnan pine nut extract and preparation process and use thereof |
12/31/2003 | CN1132606C Medicine for curing coronary heart disease with hypertension and its preparation process |
12/31/2003 | CN1132596C Chinese medicine 'Zhidakang' for treating haemorrhoids and its preparing process |
12/31/2003 | CN1132593C Mixture of white pepper and borneol and its application |
12/31/2003 | CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin |
12/31/2003 | CA2493865A1 The use of benzisoselenazolone compounds against ischemic myocardial damage |
12/31/2003 | CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
12/31/2003 | CA2491209A1 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
12/31/2003 | CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
12/31/2003 | CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
12/31/2003 | CA2490526A1 Hetero-bicyclic compounds |
12/31/2003 | CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents |
12/31/2003 | CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
12/31/2003 | CA2490121A1 Modified phospholipids |
12/31/2003 | CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof |
12/31/2003 | CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
12/31/2003 | CA2490108A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
12/31/2003 | CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same |
12/31/2003 | CA2489997A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
12/31/2003 | CA2489702A1 Novel anticholesterol compositions and method for using same |
12/31/2003 | CA2489359A1 Propionic acid derivatives and their use as hppars activators |
12/31/2003 | CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators |
12/31/2003 | CA2487909A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
12/31/2003 | CA2487718A1 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
12/31/2003 | CA2487346A1 Cannabinoid receptor agonists |
12/31/2003 | CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists |
12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
12/30/2003 | US6670478 Process for preparing torsemide intermediate |
12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
12/30/2003 | US6670455 Use of a chromatography separation processes and/or fractional precipitation |
12/30/2003 | US6670400 Secretion inhibitors for gastric acid, antiemetics; N(4-(2-(2-methoxyphenoxy)ethyl)aminobutyl)benzamide; |
12/30/2003 | US6670399 Contacting a blood vessel wall cell with an A beta 40 inhibitor, such that cerebral amyloid angiopathy is inhibited |
12/30/2003 | US6670396 Aspirin-triggered lipid mediators |
12/30/2003 | US6670389 Laulimalide derivatives |
12/30/2003 | US6670382 Hydroxyformamidine derivatives and medicines containing the same |
12/30/2003 | US6670381 Benzamide derivatives as thrombin inhibitors |
12/30/2003 | US6670380 Pyridone inhibitors of fatty acid binding protein and method |
12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
12/30/2003 | US6670367 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists |
12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
12/30/2003 | US6670364 Antagonists of MCP-1 function and methods of use thereof |
12/30/2003 | US6670362 Pyridazine endothelin antagonists |
12/30/2003 | US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders |
12/30/2003 | US6670358 Substituted thioacetamides |
12/30/2003 | US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen |
12/30/2003 | US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone |
12/30/2003 | US6670164 Isolated human kinase proteins |
12/30/2003 | US6670138 Method of diagnosing ischemic stroke via UCP-2 detection |
12/30/2003 | US6670136 Peptide for use in the treatment of inflammation defects |
12/30/2003 | US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders |
12/30/2003 | US6669957 Solid pills/pharmaceutical comprising paracetamol or tramadol dispersed in diluents and vinyl acetate-vinylpyrrolidinone copolymer as excipients, to form tablets having good texture and taste |
12/30/2003 | US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
12/30/2003 | US6669952 Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol |
12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
12/30/2003 | US6668527 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
12/30/2003 | CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists |
12/30/2003 | CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate |
12/29/2003 | WO2004002469A1 Isoflavone concentrate and method for production thereof |
12/29/2003 | CA2448513A1 Isoflavone concentrates, as well as methods for their production |
12/25/2003 | WO2003105611A2 Beverages containing plant sterols |
12/25/2003 | US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors |
12/25/2003 | US20030236405 7-hetero-bicyclo[2.2.1]-heptanes |
12/25/2003 | US20030236389 Proteins, polynucleotides encoding them and methods of using the same |
12/25/2003 | US20030236309 Novel formate salt of O-desmethyl-venlafaxine |
12/25/2003 | US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders |
12/25/2003 | US20030236278 Serotonine receptors antagonist; central nervous system disorders |
12/25/2003 | US20030236273 Aryl substituted pyrimidines and the use thereof |
12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
12/25/2003 | US20030236269 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
12/25/2003 | US20030236267 Benzimidazole derivatives |
12/25/2003 | US20030236263 Chemical compounds |
12/25/2003 | US20030236261 Potassium channel inhibitors |
12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
12/25/2003 | US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease |
12/25/2003 | US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
12/25/2003 | US20030236240 Macrocycles useful in the treatment of alzheimer's disease |